| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
24,931 |
21,225 |
$1.75M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13,422 |
12,752 |
$511K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12,641 |
11,393 |
$478K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,367 |
4,313 |
$449K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,158 |
4,080 |
$427K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,432 |
3,360 |
$383K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,723 |
3,496 |
$364K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,241 |
3,021 |
$333K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,769 |
10,929 |
$180K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
11,052 |
5,337 |
$169K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,762 |
2,315 |
$30K |
| 99381 |
|
321 |
184 |
$19K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
974 |
913 |
$17K |
| 96160 |
|
3,903 |
3,839 |
$15K |
| 96127 |
|
2,912 |
2,843 |
$13K |
| 96161 |
|
2,588 |
2,115 |
$8K |
| 99173 |
|
3,638 |
3,568 |
$7K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
172 |
166 |
$7K |
| 87807 |
|
421 |
402 |
$6K |
| 0071A |
|
135 |
118 |
$5K |
| 0002A |
|
124 |
124 |
$5K |
| 0001A |
|
121 |
121 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
450 |
420 |
$5K |
| 0072A |
|
101 |
92 |
$4K |
| 92551 |
|
1,097 |
1,081 |
$4K |
| 85018 |
|
965 |
932 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
134 |
124 |
$2K |
| 94761 |
|
555 |
512 |
$2K |
| 81003 |
|
748 |
687 |
$2K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
934 |
876 |
$287.72 |
| 86580 |
|
32 |
31 |
$255.60 |
| A7004 |
Small volume nonfiltered pneumatic nebulizer, disposable |
175 |
160 |
$66.10 |
| 90670 |
|
2,778 |
2,523 |
$58.23 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
95 |
88 |
$49.65 |
| 97802 |
|
6,904 |
6,797 |
$21.69 |
| 97803 |
|
3,908 |
3,827 |
$3.47 |
| 36416 |
|
936 |
903 |
$2.80 |
| 91300 |
|
194 |
177 |
$1.32 |
| 90681 |
|
809 |
681 |
$0.00 |
| 90648 |
|
195 |
182 |
$0.00 |
| 90734 |
|
999 |
984 |
$0.00 |
| 90715 |
|
271 |
266 |
$0.00 |
| 90633 |
|
1,348 |
1,314 |
$0.00 |
| 90700 |
|
192 |
187 |
$0.00 |
| 90707 |
|
150 |
149 |
$0.00 |
| 90710 |
|
133 |
130 |
$0.00 |
| 90649 |
|
14 |
14 |
$0.00 |
| 90685 |
|
45 |
43 |
$0.00 |
| 90647 |
|
1,460 |
1,281 |
$0.00 |
| 90651 |
|
1,164 |
1,137 |
$0.00 |
| 90686 |
|
5,390 |
5,253 |
$0.00 |
| 90723 |
|
2,089 |
1,855 |
$0.00 |
| 90696 |
|
126 |
120 |
$0.00 |
| 90620 |
|
550 |
541 |
$0.00 |
| 91307 |
|
187 |
173 |
$0.00 |
| 90716 |
|
94 |
93 |
$0.00 |
| 90619 |
|
56 |
54 |
$0.00 |
| 90680 |
|
14 |
13 |
$0.00 |